Literature DB >> 4087701

Low incidence of IgA nephropathy in blacks.

J C Jennette, S D Wall, A S Wilkman.   

Abstract

The clinical and pathologic features were evaluated in 106 IgA nephropathy patients identified in 1,753 consecutive patients undergoing renal biopsy in the southeastern United States. Special attention was paid to the proportion of Blacks among the IgA nephropathy patients compared with non-IgA nephropathy patients, and any differences in clinical or pathologic findings between Whites and Blacks with IgA nephropathy. The incidence of IgA nephropathy was approximately six times lower in Blacks (6 out of 461) than in Whites (100 out of 1,292) undergoing renal biopsy (P less than 0.001). There were no morphologic or immunohistopathologic differences between Whites and Blacks with IgA nephropathy. The only clinical difference was a marked shift in the male to female sex ratio from 3.5:1 in Whites to 1:5 in Blacks (P less than 0.004). The low incidence and reversed sex ratio of IgA nephropathy in Blacks were also supported by a review of previously published data.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4087701     DOI: 10.1038/ki.1985.222

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

Review 1.  Do genetic factors play a role in Berger's disease?

Authors:  M Levy
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

Review 2.  IgA nephropathy in children and adults.

Authors:  N Yoshikawa; H Nakamura; H Ito
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.

Authors:  M Colleen Hastings; Zina Moldoveanu; Bruce A Julian; Jan Novak; John T Sanders; Kim R McGlothan; Ali G Gharavi; Robert J Wyatt
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 8.237

4.  Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred.

Authors:  V Scivittaro; L Gesualdo; E Ranieri; C Marfella; S A Schewn; S N Emancipator; F P Schena
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

5.  Regionalization in hereditary IgA nephropathy.

Authors:  R J Wyatt; M L Rivas; B A Julian; P A Quiggins; S Y Woodford; R G McMorrow; R W Baehler
Journal:  Am J Hum Genet       Date:  1987-07       Impact factor: 11.025

6.  Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.

Authors:  Hiroyuki Kobori; Akemi Katsurada; Yuri Ozawa; Ryousuke Satou; Kayoko Miyata; Naoki Hase; Yuki Suzaki; Tatsuya Shoji
Journal:  Biochem Biophys Res Commun       Date:  2007-04-26       Impact factor: 3.575

7.  Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group.

Authors:  R J Hogg; F G Silva; R J Wyatt; J S Reisch; J C Argyle; D A Savino
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

8.  A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy.

Authors:  Koichi Nakanishi; Mayumi Sako; Nahoko Yata; Noriyuki Aoyagi; Kandai Nozu; Ryojiro Tanaka; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2003-11-28       Impact factor: 3.714

Review 9.  Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.

Authors:  Mototsugu Tanaka; George Seki; Tomonosuke Someya; Michio Nagata; Toshiro Fujita
Journal:  Clin Dev Immunol       Date:  2011-01-24

10.  Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32.

Authors:  Lucy V Holmes; Lisa Strain; Scott J Staniforth; Iain Moore; Kevin Marchbank; David Kavanagh; Judith A Goodship; Heather J Cordell; Timothy H J Goodship
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.